Old Web
English
Sign In
Acemap
>
Paper
>
评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性
评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性
2020
Andreas Wollenberg
Lisa A. Beck
Andrew Blauvelt
Eric L. Simpson
Zhen Chen
Q. Chen
B. Shumel
F.A. Khokhar
Thomas Hultsch
E. Rizova
A.B. Rossi
N. M. H. Graham
Gianluca Pirozzi
Y. Lu
Marius Ardeleanu
Keywords:
Dupilumab
Medicine
Dermatology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]